ClearPoint Neuro, Inc. (CLPT) Misses Q3 EPS by 1c

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q3 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $8.12 million versus the consensus estimate of $7.78 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
• Citizens Starts NRC Group Holdings Corp. (NRCG) at Market Outperform
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight